Literature DB >> 18381112

Benign gynecologic conditions.

Kevin J Boyle1, Saioa Torrealday.   

Abstract

Benign gynecologic conditions constitute the majority of the general gynecologist's practice. Along with health maintenance examinations, contraceptive management, family planning issues, and concerns about incontinence, the gynecologic conditions for which patients commonly present include adnexal masses, leiomyomata, endometriosis, and pelvic inflammatory disease. This article addresses each of these last four entities and incorporates a discussion of their etiologies, clinical presentations, keys to diagnosis, and the various treatment options available.

Entities:  

Mesh:

Year:  2008        PMID: 18381112     DOI: 10.1016/j.suc.2007.12.001

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  5 in total

1.  Computed tomography imaging features of benign ovarian Brenner tumors.

Authors:  Yuying Zhao; Xinfeng Mao; Lidi Yao; Jian Shen
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

Review 2.  Cowden syndrome: a critical review of the clinical literature.

Authors:  Robert Pilarski
Journal:  J Genet Couns       Date:  2008-10-30       Impact factor: 2.537

3.  Uterine Cavity Abnormalities in Patients with Endometriosis in Alexandria: A Diagnostic Test Accuracy Study.

Authors:  Eman Aly Abd El Fattah
Journal:  Obstet Gynecol Int       Date:  2017-05-30

4.  The epidemiology of gynaecologic health: contemporary opportunities and challenges.

Authors:  Sarah R Hoffman; Leslie V Farland; Kemi M Doll; Wanda K Nicholson; Maya A Wright; Whitney R Robinson
Journal:  J Epidemiol Community Health       Date:  2020-10-27       Impact factor: 3.710

5.  A comparative analysis of different biofluids towards ovarian cancer diagnosis using Raman microspectroscopy.

Authors:  Panagiotis Giamougiannis; Camilo L M Morais; Rita Grabowska; Katherine M Ashton; Nicholas J Wood; Pierre L Martin-Hirsch; Francis L Martin
Journal:  Anal Bioanal Chem       Date:  2020-11-26       Impact factor: 4.142

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.